Your browser doesn't support javascript.
Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.
Han, Shasha; Cai, Jun; Yang, Juan; Zhang, Juanjuan; Wu, Qianhui; Zheng, Wen; Shi, Huilin; Ajelli, Marco; Zhou, Xiao-Hua; Yu, Hongjie.
  • Han S; Beijing International Center for Mathematical Research, Peking University, Beijing, China.
  • Cai J; Harvard Medical School, Harvard University, Boston, MA, USA.
  • Yang J; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Zhang J; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Wu Q; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  • Zheng W; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Shi H; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Ajelli M; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Zhou XH; School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
  • Yu H; Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.
Nat Commun ; 12(1): 4673, 2021 08 03.
Article in English | MEDLINE | ID: covidwho-1340997
ABSTRACT
Dynamically adapting the allocation of COVID-19 vaccines to the evolving epidemiological situation could be key to reduce COVID-19 burden. Here we developed a data-driven mechanistic model of SARS-CoV-2 transmission to explore optimal vaccine prioritization strategies in China. We found that a time-varying vaccination program (i.e., allocating vaccines to different target groups as the epidemic evolves) can be highly beneficial as it is capable of simultaneously achieving different objectives (e.g., minimizing the number of deaths and of infections). Our findings suggest that boosting the vaccination capacity up to 2.5 million first doses per day (0.17% rollout speed) or higher could greatly reduce COVID-19 burden, should a new wave start to unfold in China with reproduction number ≤1.5. The highest priority categories are consistent under a broad range of assumptions. Finally, a high vaccination capacity in the early phase of the vaccination campaign is key to achieve large gains of strategic prioritizations.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Care Rationing / Mass Vaccination / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S41467-021-24872-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Care Rationing / Mass Vaccination / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Nat Commun Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S41467-021-24872-5